Galantamine Hydrobromide |
GP-37267; R-113675 |
Approved |
|
AverTox, Nivalin, Reminyl, Razadyne, Reminyl XL |
Mainland China |
Alzheimer Disease |
null |
1981-01-01 |
Dementia; Mental Disorders; Fasting; Subarachnoid Hemorrhage; Frontotemporal Dementia; Stress Disorders, Traumatic, Acute; Dementia, Vascular; Cognition Disorders; Cocaine-Related Disorders; Obesity; Nervous System Diseases; Lewy Body Disease; Schizophrenia; Alzheimer Disease; Cognitive Dysfunction; Tobacco Use Disorder; AIDS Dementia Complex; Vascular Diseases; Memory; Autistic Disorder; Stroke; Insulin Resistance; Brain Diseases |
Details
|
Neostigmine Bromide |
|
Approved |
|
Prostigmin |
Mainland China |
Myasthenia Gravis; Flatulence; Urinary Retention |
Shanghai Sine Pharmaceutical Laboratories Co Ltd |
1995-01-01 |
Myasthenia Gravis; Headache; Flatulence; Urinary Retention |
Details
|
Metrifonate |
Bay-a-9826; Bayer-L-1359 |
Approved |
|
ProMem, Memobay, Bilarcil |
|
|
|
|
Schistosomiasis |
Details
|
Rivastigmine Tartrate |
SDZ-212-713; SDZ-ENA-713; LY-30410; LY-03011; ONO-2540; ENA-713; LY 03013; ENA-713D; LY30410 |
Approved |
Novartis Pharma Ag |
Exelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能 |
EU |
Parkinson Disease; Dementia; Alzheimer Disease |
Novartis Europharm Ltd |
1998-05-11 |
Substance-Related Disorders; Down Syndrome; Brain Injuries, Traumatic; Delirium; Neurobehavioral Manifestations; Alzheimer Disease; Parkinson Disease; Dementia; Cocaine-Related Disorders; Dementia, Vascular; Cognition Disorders |
Details
|
Pyridostigmine Bromide |
Ro-1-5130 |
Approved |
Valeant |
Regonol, Mestinon |
United States |
Lambert-Eaton Myasthenic Syndrome |
Bausch & Lomb (Singapore) Pvi Ltd |
1955-04-06 |
Dyskinesias; HIV Seropositivity; Immunologic Deficiency Syndromes; Hypotension, Orthostatic; Fibromyalgia; Diabetes Mellitus; T-Lymphocytopenia, Idiopathic CD4-Positive; Fatigue Syndrome, Chronic; Parkinson Disease; Glycogen Storage Disease Type II; Constipation; Poisoning; Prostatic Neoplasms, Castration-Resistant; Coronavirus Disease 2019 (COVID-19); Postural Orthostatic Tachycardia Syndrome; Lambert-Eaton Myasthenic Syndrome; Heart Failure; Myasthenia Gravis; Primary Dysautonomias; HIV Infections |
Details
|
Dimebolin hydrochloride |
BRN-0622478; PF-01913539; DMB-I |
Approved |
Bigespas Ltd |
Dimebon |
Russian Federation |
Rhinitis, Allergic; Dermatitis, Atopic; Hypersensitivity |
null |
1983-01-01 |
Liver Failure; Huntington Disease; Rhinitis, Allergic; Alzheimer Disease; Dementia; Dermatitis, Atopic; Hypersensitivity |
Details
|
Donepezil Hydrochloride |
DKF-310; BNAG; E-2020; E-2022; (±)-E-2020; IVL-3003; GB-5001; HZ007 |
Approved |
Eisai Co Ltd |
Memac, Eranz, Memorit, Aricept Evess, Aricept, Aricept ODT, Aricept D, 安理申, ADLARITY |
United States |
Alzheimer Disease |
Eisai Inc |
1996-11-25 |
Cognitive Dysfunction; Autistic Disorder; Aphasia; Central Nervous System Neoplasms; Multiple Sclerosis; Breast Neoplasms; Fragile X Syndrome; Brain Neoplasms; Psychology; Alzheimer Disease; Alcoholism; Hearing Loss, Sensorineural; Dementia; Parkinson Disease; Lewy Body Disease; Wounds and Injuries; Memory Disorders; Dementia, Vascular; Neoplasm Metastasis; Cognition Disorders; Subarachnoid Hemorrhage; Autism Spectrum Disorder; Supranuclear Palsy, Progressive; Drug-Related Side Effects and Adverse Reactions; Migraine Disorders; Brain Ischemia; Diabetes Mellitus, Type 2; Depression; Down Syndrome; Osteoporosis; Neurologic Manifestations; Visual Perception; Neoplasms; Attention Deficit Disorder with Hyperactivity; Smoking Cessation; Delirium; Anxiety Disorders; Sleep Wake Disorders; Fatigue; Stroke; Radiation Injuries |
Details
|
Memantine Hydrochloride/Donepezil Hydrochloride |
ADS-8704; D-797/D-324; CKD 355; BPS-034; BPDO-1603; MDX-8704 |
Approved |
Allergan Plc |
Arimenda, Namzaric |
United States |
Alzheimer Disease |
Abbvie Inc |
2014-12-23 |
Alzheimer Disease |
Details
|
Huperzine A |
SPN-817 |
Approved |
Chinese Academy Of Sciences, Mayo Clinic |
哈伯因, 双益平 |
Mainland China |
Alzheimer Disease |
Henan Taloph Pharmaceutical Stock Co Ltd |
1994-01-01 |
Schizophrenia; Brain Injuries, Traumatic; Seizures; Alzheimer Disease; Epilepsy; Learning Disabilities; Memory Disorders |
Details
|
Distigmine Bromide |
BC-51 |
Approved |
Torii Pharmaceutical Co Ltd |
Ubretid |
Japan |
Glaucoma; Cystitis; Myasthenia Gravis; Strabismus |
Torii Pharmaceutical Co Ltd |
1967-09-05 |
Myasthenia Gravis; Cystitis; Glaucoma; Strabismus |
Details
|
Pralidoxime Chloride |
2-PAM-chloride |
Approved |
Baxter International Inc |
Protopam chloride |
United States |
Poisoning |
Baxter Healthcare Corp |
1964-03-11 |
Poisoning |
Details
|
Pralidoxime Iodide |
2-PAMI; NSC-7760; 2-PAM Iodide |
Approved |
|
|
Japan |
Poisoning |
Sumitomo Dainippon |
1958-05-01 |
Poisoning |
Details
|
Eserine Salicylate |
|
Approved |
|
Synapton SR, Xalieve, Antilirium |
|
|
|
|
Insulin Resistance; Pain, Postoperative; Psychotic Disorders; Glaucoma |
Details
|
Neostigmine methylsulfate |
|
Approved |
|
Bloxiverz, Intrastigmina, Juvastigmin, Stiglyn, Metastigmin |
Japan |
Myasthenia Gravis; Muscle Hypotonia |
kyowayakuhin Co |
1936-10-01 |
Myasthenia Gravis; Flatulence; Urinary Retention; Reversal of Neuromuscular Blockade; Muscle Hypotonia |
Details
|
Naphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6 |
|
Approved |
|
新乐敦 |
|
|
|
|
|
Details
|
Dextrose/Sodium Chloride/Potassium Chloride/Floxacillin sodium |
|
Approved |
|
|
|
|
|
|
|
Details
|
Dextrose/Sodium Chloride/Potassium Chloride/Anthralin |
|
Approved |
|
|
|
|
|
|
|
Details
|
Dextrose/Sodium Chloride/Potassium Chloride/Pralidoxime Chloride |
|
Approved |
|
|
|
|
|
|
|
Details
|
Pralidoxime Chloride/Benactyzine Hydrochloride/Atropine Sulfate |
|
Approved |
|
|
|
|
|
|
Poisoning |
Details
|
Naphazoline Hydrochloride/Neostigmine methylsulfate |
|
Approved |
|
|
|
|
|
|
|
Details
|
Dihydrogalanthamine Hydrobromide |
|
Approved |
|
|
Mainland China |
Hemiplegia; Sciatica |
null |
1982-01-01 |
Hemiplegia; Sciatica |
Details
|
Securinine Nitrate |
|
Approved |
|
|
|
|
|
|
Poliomyelitis; Facial Paralysis |
Details
|
Rivastigmine |
|
Approved |
Novartis Pharma Ag |
|
|
|
|
|
Parkinson Disease; Alzheimer Disease |
Details
|
Glycopyrronium bromide/Neostigmine metilsulfate |
|
Approved |
Sintetica Gmbh |
Novistig |
|
|
Sintetica Gmbh |
2020-07-29 |
Drug Overdose; Reversal of Neuromuscular Blockade; Muscle Hypotonia; Neuromuscular Diseases |
Details
|
Atropine/Pralidoxime Chloride |
|
Approved |
Meridian Medical Technologies Inc |
DUODOTE |
United States |
Poisoning; Organophosphate Poisoning |
Meridian Medical Technologies LLC |
2002-01-17 |
Drug-Related Side Effects and Adverse Reactions; Organophosphate Poisoning; Poisoning; Drug intoxications |
Details
|
Acotiamide Hydrochloride Hydrate |
Z-338; YM-443 |
Approved |
Zeria |
Acofide |
Japan |
Dyspepsia |
null |
2013-03-25 |
Dyspepsia; Nausea |
Details
|
Galantamine Hydrobromide |
GP-37267; R-113675 |
Approved |
|
AverTox, Nivalin, Reminyl, Razadyne, Reminyl XL |
Mainland China |
Alzheimer Disease |
null |
1981-01-01 |
Dementia; Mental Disorders; Fasting; Subarachnoid Hemorrhage; Frontotemporal Dementia; Stress Disorders, Traumatic, Acute; Dementia, Vascular; Cognition Disorders; Cocaine-Related Disorders; Obesity; Nervous System Diseases; Lewy Body Disease; Schizophrenia; Alzheimer Disease; Cognitive Dysfunction; Tobacco Use Disorder; AIDS Dementia Complex; Vascular Diseases; Memory; Autistic Disorder; Stroke; Insulin Resistance; Brain Diseases |
Details
|
Neostigmine Bromide |
|
Approved |
|
Prostigmin |
Mainland China |
Myasthenia Gravis; Flatulence; Urinary Retention |
Shanghai Sine Pharmaceutical Laboratories Co Ltd |
1995-01-01 |
Myasthenia Gravis; Headache; Flatulence; Urinary Retention |
Details
|
Metrifonate |
Bay-a-9826; Bayer-L-1359 |
Approved |
|
ProMem, Memobay, Bilarcil |
|
|
|
|
Schistosomiasis |
Details
|
Rivastigmine Tartrate |
SDZ-212-713; SDZ-ENA-713; LY-30410; LY-03011; ONO-2540; ENA-713; LY 03013; ENA-713D; LY30410 |
Approved |
Novartis Pharma Ag |
Exelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能 |
EU |
Parkinson Disease; Dementia; Alzheimer Disease |
Novartis Europharm Ltd |
1998-05-11 |
Substance-Related Disorders; Down Syndrome; Brain Injuries, Traumatic; Delirium; Neurobehavioral Manifestations; Alzheimer Disease; Parkinson Disease; Dementia; Cocaine-Related Disorders; Dementia, Vascular; Cognition Disorders |
Details
|
Pyridostigmine Bromide |
Ro-1-5130 |
Approved |
Valeant |
Regonol, Mestinon |
United States |
Lambert-Eaton Myasthenic Syndrome |
Bausch & Lomb (Singapore) Pvi Ltd |
1955-04-06 |
Dyskinesias; HIV Seropositivity; Immunologic Deficiency Syndromes; Hypotension, Orthostatic; Fibromyalgia; Diabetes Mellitus; T-Lymphocytopenia, Idiopathic CD4-Positive; Fatigue Syndrome, Chronic; Parkinson Disease; Glycogen Storage Disease Type II; Constipation; Poisoning; Prostatic Neoplasms, Castration-Resistant; Coronavirus Disease 2019 (COVID-19); Postural Orthostatic Tachycardia Syndrome; Lambert-Eaton Myasthenic Syndrome; Heart Failure; Myasthenia Gravis; Primary Dysautonomias; HIV Infections |
Details
|
Dimebolin hydrochloride |
BRN-0622478; PF-01913539; DMB-I |
Approved |
Bigespas Ltd |
Dimebon |
Russian Federation |
Rhinitis, Allergic; Dermatitis, Atopic; Hypersensitivity |
null |
1983-01-01 |
Liver Failure; Huntington Disease; Rhinitis, Allergic; Alzheimer Disease; Dementia; Dermatitis, Atopic; Hypersensitivity |
Details
|
Donepezil Hydrochloride |
DKF-310; BNAG; E-2020; E-2022; (±)-E-2020; IVL-3003; GB-5001; HZ007 |
Approved |
Eisai Co Ltd |
Memac, Eranz, Memorit, Aricept Evess, Aricept, Aricept ODT, Aricept D, 安理申, ADLARITY |
United States |
Alzheimer Disease |
Eisai Inc |
1996-11-25 |
Cognitive Dysfunction; Autistic Disorder; Aphasia; Central Nervous System Neoplasms; Multiple Sclerosis; Breast Neoplasms; Fragile X Syndrome; Brain Neoplasms; Psychology; Alzheimer Disease; Alcoholism; Hearing Loss, Sensorineural; Dementia; Parkinson Disease; Lewy Body Disease; Wounds and Injuries; Memory Disorders; Dementia, Vascular; Neoplasm Metastasis; Cognition Disorders; Subarachnoid Hemorrhage; Autism Spectrum Disorder; Supranuclear Palsy, Progressive; Drug-Related Side Effects and Adverse Reactions; Migraine Disorders; Brain Ischemia; Diabetes Mellitus, Type 2; Depression; Down Syndrome; Osteoporosis; Neurologic Manifestations; Visual Perception; Neoplasms; Attention Deficit Disorder with Hyperactivity; Smoking Cessation; Delirium; Anxiety Disorders; Sleep Wake Disorders; Fatigue; Stroke; Radiation Injuries |
Details
|
Memantine Hydrochloride/Donepezil Hydrochloride |
ADS-8704; D-797/D-324; CKD 355; BPS-034; BPDO-1603; MDX-8704 |
Approved |
Allergan Plc |
Arimenda, Namzaric |
United States |
Alzheimer Disease |
Abbvie Inc |
2014-12-23 |
Alzheimer Disease |
Details
|
Huperzine A |
SPN-817 |
Approved |
Chinese Academy Of Sciences, Mayo Clinic |
哈伯因, 双益平 |
Mainland China |
Alzheimer Disease |
Henan Taloph Pharmaceutical Stock Co Ltd |
1994-01-01 |
Schizophrenia; Brain Injuries, Traumatic; Seizures; Alzheimer Disease; Epilepsy; Learning Disabilities; Memory Disorders |
Details
|
Distigmine Bromide |
BC-51 |
Approved |
Torii Pharmaceutical Co Ltd |
Ubretid |
Japan |
Glaucoma; Cystitis; Myasthenia Gravis; Strabismus |
Torii Pharmaceutical Co Ltd |
1967-09-05 |
Myasthenia Gravis; Cystitis; Glaucoma; Strabismus |
Details
|
Pralidoxime Chloride |
2-PAM-chloride |
Approved |
Baxter International Inc |
Protopam chloride |
United States |
Poisoning |
Baxter Healthcare Corp |
1964-03-11 |
Poisoning |
Details
|
Pralidoxime Iodide |
2-PAMI; NSC-7760; 2-PAM Iodide |
Approved |
|
|
Japan |
Poisoning |
Sumitomo Dainippon |
1958-05-01 |
Poisoning |
Details
|
Eserine Salicylate |
|
Approved |
|
Synapton SR, Xalieve, Antilirium |
|
|
|
|
Insulin Resistance; Pain, Postoperative; Psychotic Disorders; Glaucoma |
Details
|
Neostigmine methylsulfate |
|
Approved |
|
Bloxiverz, Intrastigmina, Juvastigmin, Stiglyn, Metastigmin |
Japan |
Myasthenia Gravis; Muscle Hypotonia |
kyowayakuhin Co |
1936-10-01 |
Myasthenia Gravis; Flatulence; Urinary Retention; Reversal of Neuromuscular Blockade; Muscle Hypotonia |
Details
|
Naphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6 |
|
Approved |
|
新乐敦 |
|
|
|
|
|
Details
|
Dextrose/Sodium Chloride/Potassium Chloride/Floxacillin sodium |
|
Approved |
|
|
|
|
|
|
|
Details
|
Dextrose/Sodium Chloride/Potassium Chloride/Anthralin |
|
Approved |
|
|
|
|
|
|
|
Details
|
Dextrose/Sodium Chloride/Potassium Chloride/Pralidoxime Chloride |
|
Approved |
|
|
|
|
|
|
|
Details
|
Pralidoxime Chloride/Benactyzine Hydrochloride/Atropine Sulfate |
|
Approved |
|
|
|
|
|
|
Poisoning |
Details
|
Naphazoline Hydrochloride/Neostigmine methylsulfate |
|
Approved |
|
|
|
|
|
|
|
Details
|
Dihydrogalanthamine Hydrobromide |
|
Approved |
|
|
Mainland China |
Hemiplegia; Sciatica |
null |
1982-01-01 |
Hemiplegia; Sciatica |
Details
|
Securinine Nitrate |
|
Approved |
|
|
|
|
|
|
Poliomyelitis; Facial Paralysis |
Details
|
Rivastigmine |
|
Approved |
Novartis Pharma Ag |
|
|
|
|
|
Parkinson Disease; Alzheimer Disease |
Details
|
Glycopyrronium bromide/Neostigmine metilsulfate |
|
Approved |
Sintetica Gmbh |
Novistig |
|
|
Sintetica Gmbh |
2020-07-29 |
Drug Overdose; Reversal of Neuromuscular Blockade; Muscle Hypotonia; Neuromuscular Diseases |
Details
|
Atropine/Pralidoxime Chloride |
|
Approved |
Meridian Medical Technologies Inc |
DUODOTE |
United States |
Poisoning; Organophosphate Poisoning |
Meridian Medical Technologies LLC |
2002-01-17 |
Drug-Related Side Effects and Adverse Reactions; Organophosphate Poisoning; Poisoning; Drug intoxications |
Details
|
Acotiamide Hydrochloride Hydrate |
Z-338; YM-443 |
Approved |
Zeria |
Acofide |
Japan |
Dyspepsia |
null |
2013-03-25 |
Dyspepsia; Nausea |
Details
|